Category: Advances in Oncology
Smoking Cessation After a Cancer Diagnosis
H&O Which types of cancer are most strongly linked to smoking? DB Twelve types of cancers are firmly linked to tobacco smoking, according to the […]
Inhibition of Cyclin-Dependent Kinases 4 and 6 in Breast Cancer
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Inhibition of Cyclin-Dependent Kinases 4 and 6 in Breast Cancer Erica L. Mayer, […]
Combination Therapies for Treating Metastatic Melanoma
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Hussein Tawbi, MD, PhD Associate Professor of Medicine, Clinical & Translational Science, University […]
The Role of Third-Generation Epithelial Growth Factor Receptor Inhibitors in Non–Small Cell Lung Cancer
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Lecia V. Sequist, MD, MPH, Associate Professor, Harvard Medical School, Boston, Massachusetts H&O How did […]
Bevacizumab vs EGFR Antibodies in Metastatic Colorectal Cancer
Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2 Alan P. Venook, MD, Professor, Department of Medicine, Hematology/Oncology, University of California, San Francisco H&O […]
The Use of Granulocyte-Macrophage Colony-Stimulating Factor in Melanoma Treatment
Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2 F. Stephen Hodi, MD, Associate Professor, Harvard Medical School and Dana-Farber Cancer Institute, Boston, Massachusetts […]
Extending Endocrine Therapy in Women With Hormone Receptor–Positive Breast Cancer
Clinical Advances in Hematology & Oncology January 2015, Volume 13, Issue 1 Paul E. Goss, FRCP, MB BCh, PhD, Professor, Harvard Medical School, Director, Breast Cancer Research, Massachusetts General […]
The Next Generation of Targeted Therapy Trials in Colorectal Cancer
Clinical Advances in Hematology & Oncology December 2014, Volume 12, Issue 12 Peter J. O’Dwyer, MD, Professor of Medicine, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania […]
Immunotherapy for Melanoma Using Programmed Death 1 Checkpoint Inhibitors
Clinical Advances in Hematology & Oncology November 2014, Volume 12, Issue 11 Omid Hamid, MD, Chief of Research/Immuno-Oncology, Director of Melanoma Program, The Angeles Clinic and Research Institute, Los Angeles, […]
The Promise of Liquid Biopsy in Colorectal Cancer
Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 Luis Alberto Diaz, MD Associate Professor of Oncology, The Johns Hopkins University School of […]
Molecular Profiling for DCIS
Clinical Advances in Hematology & Oncology September 2014, Volume 12, Issue 9 Christy A. Russell, MD, Associate Professor of Clinical Medicine, Director of USC Norris Breast Center, Los […]
The Effect of Diet and Supplements on Prostate Cancer
Clinical Advances in Hematology & Oncology August 2014, Volume 12, Issue 8 Stephen J. Freedland, MD Associate Professor of Surgery, Associate Professor in Pathology, Duke University School of […]
Immunoconjugates in the Treatment of Breast Cancer
July 2014, Volume 12, Issue 7 Debu Tripathy, MD Professor of Medicine, Priscilla and Art Ulene Chair in Women’s Cancer, Keck School of Medicine, University of Southern California, Los Angeles, […]
Maintenance Therapy in Metastatic Colorectal Cancer
Clinical Advances in Hematology & Oncology June 2014, Volume 12, Issue 6 John L. Marshall, MD, Chief, Hematology and Oncology, Director, Ruesch Center for the Cure of GI Cancers, Medstar […]
Prostate Cancer in Focus: The Potential Role of Antigen Spread in Immunotherapy for Prostate Cancer
Clinical Advances in Hematology & Oncology May 2014, Volume 12, Issue 5 Charles G. Drake, MD, PhD Associate Professor Oncology, Immunology, and Urology Johns Hopkins Sidney […]
Aspirin, the New Targeted Therapy in Colorectal Cancer
Clinical Advances in Hematology & Oncology March 2014, Volume 12, Issue 3 Charles S. Fuchs, MD, MPH Director, Gastrointestinal Cancer Center Dana-Farber Cancer Institute, Professor of Medicine, Harvard Medical School, Boston, […]
New Research on the Treatment of Small HER2-Positive Breast Cancers
Clinical Advances in Hematology & Oncology February 2014, Volume 12, Issue 2 New Research on the Treatment of Small HER2-Positive Breast Cancers Ian E. Krop, MD, […]
Colorectal Cancer in Focus: Testing for RAS Mutations in Patients With Metastatic Colorectal Cancer
Clinical Advances in Hematology & Oncology January 2014, Volume 12, Issue 1 Heinz-Josef Lenz, MD Professor of Medicine and Preventive Medicine Division of Medical Oncology Keck School of […]
Breast Cancer in Focus: Management of the Axilla in Breast Cancer Patients Undergoing Neoadjuvant Therapy
Clinical Advances in Hematology & Oncology December 2013, Volume 11, Issue 12 Julia White, MD Professor, Department of Radiation Oncology Director, Breast Radiation Oncology, Stefanie Spielman Comprehensive […]
Radium-223, the Newest Option in Metastatic Castration-Resistant Prostate Cancer
Clinical Advances in Hematology & Oncology December 2013, Volume 11, Issue 12 Radium-223, the Newest Option in Metastatic Castration-Resistant Prostate Cancer Oliver Sartor, MD, LaBorde Professor for […]